Heart failure & cardiomyopathies

Lung Diffusion Capacity Correlates with Pre-Implant Pulmonary Hypertension and Predicts Outcome After Left Ventricle Assist Device (LVAD) Implantation

ESC Heart FailPublished Retrospective cohort study

Authors' conclusion

Before LVAD implantation, DLCO impairment is associated with higher PVR and DPG, suggesting that it might be an expression of persistent pulmonary damage occurring in Cpc-PH. After LVAD implantation, both LV dimension and haemodynamics improve. Lower pre-implant DLCO is associated with better LV reverse remodelling.

Study context

Population
Patients with advanced heart failure (HF) implanted with an LVAD35 post-capillary pulmonary hypertension (PH)
Participants
42 patients
Outcome
Impact of pre-implant DLCO and central haemodynamics on outcome
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

DLCO inversely correlated with pulmonary vascular resistance (PVR)

P 0.037

DLCO inversely correlated with diastolic pulmonary gradient (DPG)

P 0.042

Lower DLCO and Cpc-PH at baseline associated with better LV reverse remodelling (LVDd)

P 0.027

Lower DLCO and Cpc-PH at baseline associated with smaller gain in pulmonary artery compliance

P 0.049

Observational data: associations, not effects.

Further findings

Post-LVAD vs baseline changes

Improvement in LV diameter (LVDd)
P < 0.001
Improvement in mitral regurgitation
P 0.022
mPAP 24 vs. 36 mmHg
P < 0.001
PAWP 12 vs. 23 mmHg
P 0.001
Pulmonary artery compliance 3.1 vs. 1.9 mL/mmHg
P 0.021

Original publication

Lung Diffusion Capacity Correlates with Pre-Implant Pulmonary Hypertension and Predicts Outcome After LVAD Implantation. ESC Heart Fail. Published 22 December 2022. doi:10.1002/ehf2.14256

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.